The socioeconomic impact of hepatitis C infection and liver transplantation in Mexico.
Nahum
N
Méndez-Sánchez
D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000191:economics* / Q000453:epidemiology / Q000601:surgery / Q000821:virology; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D018450:Disease Progression; D016527:Drug Costs; D017048:Health Care Costs; D006297:Health Services Accessibility / Q000191:economics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology; D006801:Humans; D008103:Liver Cirrhosis / Q000191:economics* / Q000453:epidemiology / Q000601:surgery / Q000821:virology; D008113:Liver Neoplasms / Q000191:economics* / Q000453:epidemiology / Q000601:surgery / Q000821:virology; D016031:Liver Transplantation / Q000191:economics*; D008800:Mexico / Q000453:epidemiology; D015995:Prevalence; D012959:Socioeconomic Factors
D000998:Antiviral Agents